MND1 protein mediates DNA damage repair and is a promising novel therapeutic target in hepatocellular carcinoma
Cheng Wang, Minghua Hu, Wanyu Xia, Qian Zheng, Chengfei Zhang, Ruoyu Shi, Chengsong Cao, Hongping Xia, Chengyun Yao · 2026
Read MND1 protein mediates DNA damage repair and is a promising novel therapeutic target in hepatocellular carcinoma by Cheng Wang, Minghua Hu, Wanyu Xia, Qian Zheng, Chengfei Zhang, Ruoyu Shi, Chengsong Cao, Hongping Xia, Chengyun Yao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13649621.txt.
Description
Cheng Wang and co-authors identify a DNA-repair protein, MND1, as a promising drug target in liver cancer, in a 2026 study. Liver cancer remains a leading cause of cancer death worldwide. Fresh targets are urgently needed. Data mining first flagged MND1 as overactive in tumors. Its ties to DNA damage repair hinted at a growth role.
The team profiled its expression across tumor samples. Lab work then probed how it drives cancer progression. A repair protein can help tumors survive their own damage. Blocking it might sensitize cancers to existing drugs. Oncologists gain a candidate with mechanism attached. The study runs from database signals to cell biology. Validation in animals is the usual next step.
Catalog record
| CREATOR | Cheng Wang, Minghua Hu, Wanyu Xia, Qian Zheng, Chengfei Zhang, Ruoyu Shi, Chengsong Cao, Hongping Xia, Chengyun Yao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |